/Companies

All in Bio

2 known investors

Find your way into All in Bio

Sign up to see every warm intro you have to All in Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the All in Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.

Investors · 2

Frequently asked questions

What does All in Bio do?
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
Who are All in Bio's investors?
All in Bio's investors include +ND Capital, Artis Ventures.